logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Debra L. Richardson

university of oklahoma and sarah cannon research institute
H指数:27
被引数:3,759

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer

Ib期临床试验：评估SL-172154（一种双特异性CD47抑制剂和CD40激动剂Fc融合蛋白）联合mirvetuximab soravtansine或脂质体多柔比星治疗铂耐药性卵巢癌患者的疗效。

British Journal of Cancer
IF6.8
2026-04-080
PRE
Yvette Drew; Lucy Gilbert; Alejandro Martinez Bueno; Ana Oaknin; Victor Moreno; Lydia Gaba Garcia; Gordon C. Jayson; Rebecca S. Kristeleit; Nehal Lakhani; Susana Banerjee; Daniela Matei; Amit Oza; Rowan Miller; Dennis Yiannakis; Maria-Pilar Barretina-Ginesta; Jerónimo Martínez García; Guanfang Wang; Jayalakshmi Miriyala; Amy Franke; Elisa Galvez; Lini Pandite; Debra L. Richardson
Corrigendum to ‘OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer’ [Gynecol Oncol 2025 Jun 197 182–191]

勘误：‘OVATION-2：一项评估IMNN-001（IL-12基因疗法）联合新辅助化疗在 newly-diagnosed advanced epithelial ovarian cancer 患者中安全性与有效性的随机I/II期研究’ [Gynecol Oncol 2025 Jun 197 182–191]

Gynecologic Oncology
IF3.7
2025-11-060
PRE
Premal H. Thaker; Debra L. Richardson; Andrea R. Hagemann; Robert W. Holloway; Mark Reed; Melanie K. Bergman; Bhavana Pothuri; Stephen DePasquale; Jennifer M. Scalici; Amy J. Bregar; Christopher J. Darus; Karen Finkelstein; Charles A. Leath; Maria Bell; David P. Warshal; Richy Agajanian; Megan D. Indermaur; Alberto A. Mendivil; Diane M. Provencher; Lee-Jen Wei; Nicholas Borys; Lauren Musso; Stacy R. Lindborg; Douglas V. Faller; Khursheed Anwer; William H. Bradley
Feasibility IB trial of paclitaxel/carboplatin + Galunisertib. (a small molecule inhibitor of the kinase domain of type 1 TGF-B receptor) in patients with newly diagnosed, persistent or recurrent carcinosarcoma of the uterus or ovary

I期可行性试验：评估紫杉醇/卡铂联合Galunisertib（一种抑制1型TGF-B受体激酶域的小分子抑制剂）在初诊、持续性或复发性子宫或卵巢癌肉瘤患者中的疗效。

Gynecologic Oncology
IF3.7
2025-11-050
PRE
C. Washington; Shailendra Kumar Dhar Dwivedi; C. Gunderson-Jackson; J. Walker; R.S. Mannel; L.L. Holman; D.L. Richardson; D. Neelakantan; A. Cohoon; K. Ding; Z. Gatalica; K.M. Moxley; L.M. Landrum; M.R. Rowland; R. Bhattacharya; K.N. Moore
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO

在一项关于 niraparib 联合 bevacizumab 维持治疗的研究中，该研究在晚期卵巢癌患者接受以 bevacizumab 辅助的一线铂类化疗后进行，报告了 OVARIO 研究的最终分析结果及总生存数据。

gynecologic oncology
IF4.1
2025-07-010
OA
Melissa M. Hardesty; Thomas C. Krivak; Gail S. Wright; Erika Hamilton; Evelyn L. Fleming; Jimmy Belotte; Shelby Gorman; Natalie Compton; Aine Clements; Heidi J. Gray; Gottfried E. Konecny; Richard G. Moore; Debra L. Richardson
Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial*

将三氮烯（T）整合到顺铂化疗放疗（CRT）中治疗局部晚期宫颈癌和阴道癌：NRG-GY006 III期随机试验*的结果

gynecologic oncology
IF4.1
2025-04-010
PRE
Leath III, Charles A.; Deng, Wei; Mell, Loren K.; Richardson, Debra L.; Walker, Joan L.; Holman, Laura L.; Lea, Jayanthi S.; Amarnath, Sudha R.; Santos-Reyes, Luis Javier; Arend, Rebecca C.; Mayadev, Jyoti; Jegadeesh, Naresh; Disilvestro, Paul; Chon, Hye Sook; Ghamande, Sharad A.; Gao, Lei; Albuquerque, Kevin; Chino, Junzo P.; Donnelly, Eric; Feddock, Jonathan M.; Lowenstein, Jessica; Quick, Allison M.; Kunos, Charles M.; Macka, Helen; Aghajanian, Carol; Monk, Bradley J.
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)
BMC CANCER
IF3.4
2025-03-180
OAAI
Marbach, Daniel; Brouer-Visser, Jurriaan; Brennan, Laura; Wilson, Sabine; Davydov, Iakov I.; Staedler, Nicolas; Duarte, Jose; Quetglas, Iris Martinez; Nueesch, Eveline; Canamero, Marta; Chesne, Evelyne; Au-Yeung, George; Hamilton, Erika; Lheureux, Stephanie; Richardson, Debra L.; Spanggaard, Iben; Gomes, Bruno; Franjkovic, Izolda; Demario, Mark; Kornacker, Martin; Lechner, Katharina
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer

首次人体I期临床试验，评估双特异性CD47抑制剂和CD40激动剂Fc融合蛋白SL-172154在铂耐药卵巢癌患者中的应用

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2025-01-111
OA
Lakhani, Nehal J.; Stewart, Daphne; Richardson, Debra L.; Dockery, Lauren E.; Van Le, Linda; Call, Justin; Rangwala, Fatima; Wang, Guanfang; Ma, Bo; Metenou, Simon; Huguet, Jade; Offman, Elliot; Pandite, Lini; Hamilton, Erika
A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors

尼拉帕尼片在晚期实体瘤患者中的相对生物利用度，生物等效性和食物效应研究

CLINICAL THERAPEUTICS
IF3.6
2024-03-010
OAAI
Falchook, Gerald; Patnaik, Amita; Richardson, Debra L.; Harvey, R. Donald; Sharma, Manish R.; Hafez, Navid; Hamilton, Erika; Piha-Paul, Sarina A.; Barve, Minal; Wise-Draper, Trisha; Patel, Manish R.; Dowlati, Afshin; Pascuzzo, Joseph; Tang, Shou-Ching; Faltermeier, Christina; Malinowska, Izabela A.; Shtessel, Luda; Striha, Alina; Potocka, Elizabeth
VP2-2022: Prospective double-blind, randomized phase III ENGOT-EN5/GOG-3055/SIENDO study of oral selinexor/placebo as maintenance therapy after first-line chemotherapy for advanced or recurrent endometrial cancer
ANNALS OF ONCOLOGY
IF65.4
2022-04-018
PRE
Vergote, I. B.; Fidalgo, A. Pyrez; Hamilton, E.; Valabrega, G.; Van Gorp, T.; Sehouli, J.; Cibula, D.; Levy, T.; Welch, S.; Richardson, D. L.; Alia, E. M. Guerra; Scambia, G.; Henry, S.; Wimberger, P.; Miller, D.; Martinez, J.; Monk, B. J.; Shacham, S.; Mirza, M. R.; Makker, V.

研究方向

暂未获取到该数据
E
Erika Hamilton
H 指数:58论文数:843被引数:1.6万
K
Kathleen N. Moore
H 指数:84论文数:1,090被引数:4.7万
C
Christina Chu
H 指数:41论文数:180被引数:8,632
N
Nehal J. Lakhani
H 指数:28论文数:283被引数:4,385
M
Minal Barve
H 指数:33论文数:414被引数:6,991
R
Rebecca C. Arend
H 指数:44论文数:418被引数:6,539
K
Kimberly A. Kho
H 指数:19论文数:119被引数:1,753
L
Leigh G. Seamon
H 指数:25论文数:102被引数:2,465
A
Afshin Dowlati
H 指数:66论文数:703被引数:3.2万
S
Susana Banerjee
H 指数:71论文数:667被引数:3.0万